NASDAQ · NXGL
Healthcare · Medical - Instruments & Supplies
$3.51
Down-$0.37 (-9.54%)
Updated Oct 31, 2026, 5:21 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NXGL
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NXGL closed at $3.51 after 21 trading sessions, up 1917.24% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.75 | $3.895 | $3.50 | $3.51 | 60.14K |
| Oct 29, 2026 | $3.755 | $3.98 | $3.75 | $3.88 | 14.58K |
| Oct 28, 2026 | $4.23 | $4.30 | $3.80 | $4.03 | 53.09K |
| Oct 27, 2026 | $3.86 | $4.255 | $3.61 | $4.255 | 61.66K |
| Oct 26, 2026 | $4.68 | $4.7599 | $3.90 | $3.96 | 48.51K |
| Oct 23, 2026 | $4.72 | $5.26 | $4.7122 | $5.03 | 54.36K |
| Oct 22, 2026 | $5.29 | $5.45 | $4.7216 | $4.76 | 31.67K |
| Oct 21, 2026 | $5.00 | $5.50 | $4.92 | $5.28 | 54.21K |
| Oct 20, 2026 | $5.80 | $5.80 | $4.50 | $5.33 | 28.71K |
| Oct 19, 2026 | $5.55 | $5.90 | $5.53 | $5.80 | 50.19K |
| Oct 16, 2026 | $5.18 | $5.87 | $5.09 | $5.59 | 54.79K |
| Oct 15, 2026 | $4.91 | $5.53 | $4.0635 | $5.18 | 165.71K |
| Oct 14, 2026 | $4.05 | $7.25 | $3.91 | $5.46 | 3.34M |
| Oct 13, 2026 | $3.88 | $4.07 | $3.68 | $4.05 | 74.73K |
| Oct 12, 2026 | $3.96 | $4.4294 | $3.25 | $3.81 | 197.32K |
| Oct 9, 2026 | $3.12 | $4.406 | $3.02 | $4.006 | 524.78K |
| Oct 8, 2026 | $3.00 | $3.60 | $3.00 | $3.00 | 67.25K |
| Oct 7, 2026 | $3.40 | $3.792 | $3.244 | $3.544 | 31.87K |
| Oct 6, 2026 | $3.40 | $3.474 | $3.302 | $3.458 | 16.05K |
| Oct 5, 2026 | $0.17 | $0.1727 | $0.1641 | $0.17 | 291.32K |
| Oct 2, 2026 | $0.174 | $0.174 | $0.163 | $0.174 | 222.91K |
The latest Smart Investors Daily articles mentioning NXGL.
Company
Market Activity
Research & News
NXGL research
Company profile and research snapshot.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Maxim Group | Hold | — |
| Mar 12, 2026 | Maxim Group | Buy | — |
| Feb 25, 2022 | Maxim Group | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 27, 2026
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL), a company with a patient-centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive
Benzinga · Oct 12, 2026
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that
ChartMill · Oct 9, 2026
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Benzinga · Oct 7, 2026
Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million. Profound Medical (NASDAQ:PROF) stock rose 16.98% to $6.64.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NXGL.
